Garry E. Menzel - 07 Jun 2022 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Director
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
07 Jun 2022
Net transactions value
$0
Form type
4
Filing time
08 Jun 2022, 17:00:49 UTC
Previous filing
18 Mar 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Director Stock Option (Right to Buy) Award $0 +21,000 $0.000000 21,000 07 Jun 2022 Common Stock 21,000 $12.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.